Table 2.

Changes in Outcome at End-Of-Treatment, Data Pooled from Both Groups^*

Outcome	Change at EOT* [95% CI]	P Value
Change in score on LE Fugl-Meyer Assessment	1.4 [0.4, 2.4]	<0.01
Change in maximum dorsiflexion angle (°)	6.5 [2.1, 10.9]	<0.01
Change in ankle movement tracking error **	−1.9 [−3.3, −0.5]	0.01
Change in maximum dorsiflexion moment (Nm)	1.4 [0.2, 2.6]	0.02
Change in time to complete mEFAP (sec) **	−6.3 [−11.1, −1.5]	0.01
Change in dorsiflexion angle at initial contact (°)	−0.7 [−2.3, 0.9]	0.41
Change in peak knee flexion during swing (°)	−0.1 [−4.0, 3.8]	0.96
Change in peak hip flexion during swing (°)	0.0 [−2.5, 2.5]	0.97
Change in gait velocity (cm/sec)	2.1 [−1.2, 5.4]	0.21
Change in stride length (cm)	2.9 [−0.7, 6.5]	0.12
Change in cadence (steps/min)	−0.2 [−2.2, 1.8]	0.81

Abbreviations: CCNMES, contralaterally controlled neuromuscular electrical stimulation; CYCLIC, cyclic neuromuscular electrical stimulation; EOT, end of treatment; LE, lower extremity; mEFAP, modified Emory Functional Ambulation Profile

^*Change estimates at end-of-treatment derived from linear mixed model.

^**On this scale, a reduction in the score indicates improvement in the condition being evaluated.